Canada Gazette
www.gazette.gc.ca
Common menu bar links
Vol. 139, No. 10 — March 5, 2005
COMMISSIONS
CANADA BORDER SERVICES AGENCY
SPECIAL IMPORT MEASURES ACT
Certain laminate flooring — Decision
On February 16, 2005, the President, Canada Border Services Agency (CBSA), made a preliminary determination of dumping, pursuant to subsection 38(1) of the Special Import Measures Act (SIMA), respecting laminate flooring in thickness ranging from 5.5 mm to 13 mm (other than laminate hardwood flooring where the hardwood component exceeds 2 mm in thickness) originating in or exported from Austria, Belgium, the People's Republic of China, France, the Federal Republic of Germany and the Republic of Poland and a preliminary determination of subsidy of laminate flooring in thickness ranging from 5.5 mm to 13 mm (other than laminate hardwood flooring where the hardwood component exceeds 2 mm in thickness) originating in or exported from the People's Republic of China.
On the same date, pursuant to paragraph 35(2)(a) of SIMA, the President terminated the dumping investigation of such product originating in or exported from Luxembourg.
The goods in question are properly classified under the Harmonized System classification number 4411.19.90.90.
The Canadian International Trade Tribunal (the Tribunal) will conduct a full inquiry into the question of injury to the domestic industry and will make an order or finding not later than 120 days after its receipt of the notice of the preliminary determination of dumping and subsidizing.
Pursuant to section 8 of SIMA, provisional duty is payable on the dumped and subsidized subject goods that are released from customs during the period commencing February 16, 2005, and ending on the earlier of the day the investigation is terminated, the day on which the Tribunal makes an order or finding, or the day an undertaking is accepted. The amount of provisional duty payable is not greater than the estimated margin of dumping and the estimated amount of subsidy. The Customs Act applies with respect to the accounting and payment of provisional duty. As such, failure to pay duties within the prescribed time will result in the application of the interest provisions of the Customs Act.
Information
The statement of reasons regarding this decision will be issued within 15 days. The statement of reasons will also be available within 15 days on the CBSA's Web site at www.cbsa.gc.ca/sima/ or by contacting either Blair Hynes at (613) 954-1641, by electronic mail at Blair.Hynes@cbsa-asfc.gc.ca or by facsimile at (613) 941-2612, or Brian Hodgson at (613) 954-7237, by electronic mail at Brian.Hodgson@cbsa-asfc.gc.ca or by facsimile at (613) 941-2612.
Ottawa, February 16, 2005
SUZANNE PARENT
Director General
Anti-dumping and Countervailing Directorate
[10-1-o]
CANADA CUSTOMS AND REVENUE AGENCY
INCOME TAX ACT
Revocation of registration of a charity
The following notice of proposed revocation was sent to the charity listed below revoking it for failure to meet the parts of the Income Tax Act as listed in this notice:
"Notice is hereby given, pursuant to paragraphs 168(1)(b), 168(1)(c), 168(1)(d) and 168(1)(e) of the Income Tax Act, that I propose to revoke the registration of the charity listed below and that, by virtue of paragraph 168(2)(b) thereof, the revocation of the registration is effective on the date of publication of this notice in the Canada Gazette."
| Business Number | Name/Address |
|---|---|
| 133218628RR0001 | THE LORD'S EVANGELICAL CHURCH OF DELIVERANCE & PRAYER OF TORONTO, TORONTO, ONT. |
ELIZABETH TROMP
Director General
Charities Directorate
[10-1-o]
CANADIAN INTERNATIONAL TRADE TRIBUNAL
DECISION TO COMMENCE A GLOBAL SAFEGUARD INQUIRY — REVISED NOTICE
Bicycles and finished painted bicycle frames
Following a complaint filed by the Canadian Bicycle Manufacturers Association (CBMA), the Canadian International Trade Tribunal (the Tribunal) hereby gives notice that it is commencing, pursuant to subsection 26(1) of the Canadian International Trade Tribunal Act (CITT Act), a global safeguard inquiry (Safeguard Inquiry No. GS-2004-001) into the importation into Canada, from all sources, of bicycles, assembled or unassembled, with a wheel diameter greater than 15 inches or 38.1 centimetres, and finished painted bicycle frames, assembled or unassembled.
The purpose of the inquiry is to determine whether the goods subject to the inquiry are being imported into Canada from all sources in such increased quantities and under such conditions as to be a principal cause of serious injury, or threat thereof, to domestic producers of like or directly competitive goods.
The Tribunal will issue questionnaires to domestic producers, importers and foreign producers of bicycles and frames, requesting relevant statistical and other information for the years 2000 to 2004. The Tribunal will also issue market characteristics questionnaires to certain purchasers of bicycles and bicycle frames. Copies of these questionnaires will be available on the Tribunal's Web site by March 8, 2005, at www.citt-tcce.gc.ca/question/index_e.asp. Responses to the questionnaires will be required no later than April 5, 2005.
The Tribunal will issue a report on the inquiry no later than August 9, 2005.
Should the Tribunal make a final determination of serious injury or threat thereof, it will submit a copy of its final report to the Government of Canada, which may decide on appropriate safeguard measures.
The Tribunal's proceedings will be in accordance with the Canadian International Trade Tribunal Rules.
Participation
Each person or government wishing to participate in the Tribunal's inquiry as a party must file a notice of participation with the Secretary on or before March 11, 2005. Each counsel who intends to represent a party must file a notice of representation and, in order to have access to confidential information, a declaration and confidentiality undertaking with the Secretary on or before March 11, 2005. Forms for filing notices of participation, notices of representation, and declarations and undertakings can be found on the Tribunal's Web site at www.citt-tcce.gc.ca/forms/index_e.asp.
To allow the Tribunal to determine whether simultaneous interpretation will be required for the hearing, each party filing a notice of participation and each counsel filing a notice of representation must advise the Secretary, at the same time that they file their notices, whether they and their witnesses will be using French or English or both languages at the hearing. Requirements for interpretation in any other language should also be communicated to the Tribunal at that time.
Case briefs
Parties supporting a finding of injury shall file case briefs by May 19, 2005. Parties opposing a finding of injury shall file case briefs by May 27, 2005. Parties supporting a finding of injury shall file reply case briefs by June 3, 2005. All submissions to the Tribunal must be filed in paper and electronic formats.
Case briefs are to include three separate parts, each with a table of contents: (A) Written Submissions; (B) Witness Statements; and (C) Supporting Evidence. Written submissions shall be printed or typewritten on white paper measuring 21.5 cm by 28 cm (8 1/2 in. by 11 in.), in a type not smaller than 11 points, with top and bottom margins of not less than 2.5 cm (1 in.) and left and right margins of not less than 3.5 cm (1.5 in.), and with no more than 30 lines per page, exclusive of headings.
(A) Written Submissions
Written submissions shall include consideration of
- the matters referred to in subsections 27(1) and (2) of the CITT Act and the factors referred to in section 5 of the Canadian International Trade Tribunal Regulations (see appendix for certain key extracts);
- the global trade situation, including production, capacity, trade-restrictive actions taken or considered by other countries, and the risk of trade diversion; and
- any factors other than imports that have caused or threaten to cause serious injury to domestic producers of like or directly competitive goods in Canada.
(B) Witness Statements
Parties that intend to present witnesses shall file, for each witness, a witness statement that conveys the essential elements of the witness's testimony.
(C) Supporting Evidence
Evidence supporting a party's written submissions and/or witness statements relating to injury may include, for example, internal and public information, such as statistical data, market analyses, and industry-related publications and reports. In its written submissions, a party shall make clear reference to relevant excerpts of the documents that are included as part of its supporting evidence.
Hearing
A public hearing will be held starting on June 13, 2005, in the Tribunal's hearing room, 18th Floor, Standard Life Centre, 333 Laurier Avenue W, Ottawa, Ontario.
In advance of the hearing, the Tribunal will provide detailed information to parties on the procedures that it will apply.
Confidentiality
Under section 46 of the CITT Act, a person who provides information to the Tribunal and who wishes some or all of the information to be kept confidential must submit to the Tribunal, at the time that the information is provided, a statement designating the information as confidential, together with an explanation as to why that information is designated as confidential. Furthermore, the person must submit a non-confidential summary of the information designated as confidential or a statement indicating why such a summary cannot be made.
Further information
This notice has been sent to interested governments and departments, and to producers, importers, exporters and certain purchasers of bicycles and bicycle frames with a known interest in the inquiry. The notice will also be published in the March 5, 2005 edition ofthe Canada Gazette, Part I.
The decision on commencement and the reasons for this inquiry, which contain additional information, are available on the Tribunal's Web site at www.citt-tcce.gc.ca/safeguar/global/decision/gs2e01a_e.asp.
In order to observe and understand production processes, the Tribunal, accompanied by its staff, may conduct plant visits.
Audrey Chapman, the research director for this inquiry, can be reached at (613) 990-2436. Simon Glance, the lead research officer, can be reached at (613) 990-8142.
Information on participation in these proceedings is available from the office of the Secretary. Written submissions, correspondence or requests for information regarding this notice should be addressed to the Secretary, Canadian International Trade Tribunal, Standard Life Centre, 15th Floor, 333 Laurier Avenue W, Ottawa, Ontario K1A 0G7, (613) 993-3595 (telephone), (613) 990-2439 (facsimile), secretary@citt-tcce.gc.ca (electronic mail).
Written or oral communications to the Tribunal may be made in English or in French.
Ottawa, February 24, 2005
HÉLÈNE NADEAU
Secretary
APPENDIX
Subsections 27(1) and (2) of the CITT Act
27. (1) The Tribunal shall, in an inquiry into a complaint, determine whether, having regard to any regulations made pursuant to paragraph 40(a),
(a) in the case of a complaint filed under subsection 23(1), the goods that are the subject of the complaint are being imported in such increased quantities and under such conditions as to be a principal cause of serious injury, or threat thereof, to domestic producers of like or directly competitive goods;
. . .
(2) For the purposes of subsection (1), "principal cause" means, in respect of a serious injury or threat thereof, an important cause that is no less important than any other cause of the serious injury or threat thereof.
Section 5 of the Canadian International Trade Tribunal Regulations
5. (1) For the purposes of determining, during an inquiry into a matter referred to the Tribunal pursuant to paragraph 20(a) of the Act or an inquiry into a complaint referred to in paragraph 27(1)(a), (a.1), (a.2), (a.4), (a.5) or (b) of the Act, whether the goods that are the subject of the reference or complaint are being imported as set out in that paragraph, the Tribunal shall examine, among other factors,
(a) the actual volume of the goods imported into Canada;
(b) the effect of the imported goods on prices of like or directly competitive goods in Canada; and
(c) the impact of the imported goods on domestic producers of like or directly competitive goods in Canada.
(2) The Tribunal shall consider, with respect to the factor mentioned in paragraph (1)(a), whether there has been a significant increase in the importation into Canada of the goods and, where there has been, the rate and amount of such increase, either absolutely or relative to the production in Canada of like or directly competitive goods.
(3) The Tribunal shall consider, with respect to the factor mentioned in paragraph (1)(b),
(a) whether the prices of the imported goods have significantly undercut the prices of like or directly competitive goods produced and sold in Canada; and
(b) whether the effect of the importation into Canada of the goods has been
(i) to depress significantly the prices of like or directly competitive goods produced and sold in Canada, or(ii) to limit to a significant degree increases in the prices of like or directly competitive goods produced and sold in Canada.
(4) The Tribunal shall evaluate, with respect to the factor mentioned in paragraph (1)(c), all relevant economic factors that have a bearing on domestic producers of like or directly competitive goods, including the actual and potential changes in the level of production, employment, sales, market share, profits and losses, productivity, return on investments, utilization of production capacity, cash flow, inventories, wages, growth or ability to raise capital or investments.
[10-1-o]
CANADIAN INTERNATIONAL TRADE TRIBUNAL
INQUIRY
Scientific instruments
The Canadian International Trade Tribunal (the Tribunal) has received a complaint (File No. PR-2004-052) from Everest VIT, Inc., of Flanders, New Jersey, concerning a procurement (Solicitation No. W3474-05W500/A) by the Department of Public Works and Government Services (PWGSC) on behalf of the Department of National Defence. The solicitation is for the provision of video scopes. Pursuant to subsection 30.13(2) of the Canadian International Trade Tribunal Act and subsection 7(2) of the Canadian International Trade Tribunal Procurement Inquiry Regulations, notice is hereby given that the Tribunal has decided to conduct an inquiry into the complaint.
It is alleged that PWGSC narrowly stated the technical specifications thereby favouring one manufacturer's videoscope, to the exclusion of all other manufacturers' equipment.
Further information may be obtained from the Secretary, Canadian International Trade Tribunal, Standard Life Centre, 15th Floor, 333 Laurier Avenue W, Ottawa, Ontario K1A 0G7, (613) 993-3595 (telephone), (613) 990-2439 (facsimile).
Ottawa, February 18, 2005
HÉLÈNE NADEAU
Secretary
[10-1-o]
CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION
NOTICE TO INTERESTED PARTIES
The following notices are abridged versions of the Commission's original notices bearing the same number. The original notices contain a more detailed outline of the applications, including additional locations and addresses where the complete files may be examined. The relevant material, including the notices and applications, is available for viewing during normal business hours at the following offices of the Commission:
— Central Building, Les Terrasses de la Chaudière, Room G-5, 1 Promenade du Portage, Gatineau, Quebec K1A 0N2, (819) 997-2429 (telephone), 994-0423 (TDD), (819) 994-0218 (facsimile);
— Bank of Commerce Building, Suite 1007, 1809 Barrington Street, Halifax, Nova Scotia B3J 3K8, (902) 426-7997 (telephone), 426-6997 (TDD), (902) 426-2721 (facsimile);
— Kensington Building, Suite 1810, 275 Portage Avenue, Winnipeg, Manitoba R3B 2B3, (204) 983-6306 (telephone), 983-8274 (TDD), (204) 983-6317 (facsimile);
— 530-580 Hornby Street, Vancouver, British Columbia V6C 3B6, (604) 666-2111 (telephone), 666-0778 (TDD), (604) 666-8322 (facsimile);
— C.R.T.C. Documentation Centre, 405 De Maisonneuve Boulevard E, 2nd Floor, Suite B2300, Montréal, Quebec H2L 4J5, (514) 283-6607 (telephone), 283-8316 (TDD), (514) 283-3689 (facsimile);
— C.R.T.C. Documentation Centre, 55 St. Clair Avenue E, Suite 624, Toronto, Ontario M4T 1M2, (416) 952-9096 (telephone), (416) 954-6343 (facsimile);
— C.R.T.C. Documentation Centre, Cornwall Professional Building, Room 103, 2125 11th Avenue, Regina, Saskatchewan S4P 3X3, (306) 780-3422 (telephone), (306) 780-3319 (facsimile);
— C.R.T.C. Documentation Centre, 10405 Jasper Avenue, Suite 520, Edmonton, Alberta T5J 3N4, (780) 495-3224 (telephone), (780) 495-3214 (facsimile).
Interventions must be filed with the Secretary General, Canadian Radio-television and Telecommunications Commission, Ottawa, Ontario K1A 0N2, together with proof that a true copy of the intervention has been served upon the applicant, on or before the deadline given in the notice.
Secretary General
CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION
DECISIONS
The complete texts of the decisions summarized below are available from the offices of the CRTC.
2005-15-1 February 22, 2005
Astral Media Radio inc. and 591991 B.C. Ltd., a wholly owned subsidiary
of Corus Entertainment Inc.
Amqui, Drummondville, Rimouski, Saint-Jean-Iberville, Montréal,
Québec, Gatineau, Saguenay, Trois-Rivières, Sherbrooke,
and Lévis, Quebec
Exchange of radio assets in Quebec between Astral Media Radio inc. and Corus Entertainment Inc. — Confirmation received.
2005-69 February 23, 2005
CJNE FM Radio Inc.
Nipawin and Carrot River, Saskatchewan
Approved — Authority to acquire from Nor-Com Electronics Ltd. the assets of the radio programming undertaking CJNE-FM Nipawin and of the low-power radio programming undertaking VF2212 Carrot River, Saskatchewan, as part of a corporate reorganization.
2005-70 February 24, 2005
Golden West Broadcasting Ltd.
Kindersley, Saskatchewan
Approved — New low-power English-language FM commercial radio programming undertaking in Kindersley. The licence will expire August 31, 2011.
2005-71 February 24, 2005
Canadian Broadcasting Corporation
Vancouver and Sechelt, British Columbia
Approved — Change of channel of the transmitter CBUT-35 Sechelt from 19LP to 18LP for its television programming undertaking CBUT Vancouver.
2005-72 February 24, 2005
Canadian Broadcasting Corporation
Regina and Warmley, Saskatchewan
Approved — New transmitter in Warmley to broadcast the programming of its national English-language network service, Radio Two, for the radio programming undertaking CBK-FM Regina.
2005-73 February 24, 2005
Neepawa Access Community T.V. (ACTV) Inc.
Neepawa, Manitoba
Renewed — Renewal of the broadcasting licence for the television programming undertaking CH5248 Neepawa, from March 1 to August 31, 2005.
2005-74 February 24, 2005
591991 B.C. Ltd.
Amqui, Quebec
The Commission revokes the broadcasting licence issued to 591991 B.C. Ltd. for CFVM Amqui.
2005-75 February 24, 2005
Newcap Inc.
Bonnyville, Alberta
Approved — Extension of the time limit to commence operation of CKSA-FM-1 Bonnyville, until December 18, 2005.
2005-76 February 24, 2005
La Coopérative radiophonique de Toronto inc.
Toronto, Ontario
Approved — Extension of the time limit to commence the operation of the radio programming undertaking, until June 17, 2005.
2005-77 February 25, 2005
Standard Radio Inc.
Salmon Arm, British Columbia
Approved — New English-language FM radio programming undertaking in Salmon Arm. The licence will expire August 31, 2011.
2005-78 February 25, 2005
Rogers Broadcasting Limited
Vernon and Enderby, British Columbia
Approved — New transmitter in Enderby for the radio programming undertaking CKIZ-FM Vernon.
[10-1-o]
CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION
PUBLIC NOTICE 2005-15
The Commission has received the following applications. The deadline for submission of interventions and/or comments is March 17, 2005.
1. Groupe TVA inc.
Montréal, Québec, Trois-Rivières, Sherbrooke, Rimouski
and Saguenay, Quebec
To amend the licences of television programming undertakings CFTM-TV Montréal, CFCM-TV Québec, CHEM-TV Trois-Rivières, CHLT-TV Sherbrooke, CFER-TV Rimouski, CJPM-TV Saguenay, as well as the licence for the TVA network.
2. Télé Inter-Rives ltée
Carleton and Rivière-du-Loup, Quebec
To amend the licences of television programming undertakings CHAU-TV Carleton and CIMT-TV Rivière-du-Loup.
3. Radio Nord Communications inc.
Gatineau and Rouyn-Noranda, Quebec
To amend the licences of television programming undertakings CHOT-TV Gatineau and CFEM-TV Rouyn-Noranda.
February 25, 2005
[10-1-o]
CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION
PUBLIC NOTICE 2005-16
Call for comments on applying new distribution and linkage rules to non-Canadian third-language services already on the lists of eligible satellite services
In the notice, the Commission calls for comments on applying new distribution and linkage rules to non-Canadian third-language services already on its lists of eligible satellite services. Instructions for filing comments are set out at the end of the notice. The Commission will accept comments that it receives on or before March 29, 2005.
February 25, 2005
[10-1-o]
CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION
PUBLIC NOTICE 2005-17
Call for comments on a proposed new approach to the consideration of applications for Canadian third-language ethnic Category 2 pay and specialty services
In the notice, the Commission invites comments on a proposed new approach to the consideration of applications for Canadian third-language ethnic Category 2 pay and specialty services. Instructions for filing comments are set out at the end of the notice. The Commission will accept comments that it receives on or before March 29, 2005.
February 25, 2005
[10-1-o]
CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION
PUBLIC NOTICE 2005-18
Commission requirements for the pass-through of video description — Call for comments on the obligations of smaller broadcasting distribution undertakings
Broadcasters are stepping up their efforts to make programming accessible to persons who are blind or who have a visual impairment by increasing the amount of their programming that is accompanied by video description. The Commission's current regulatory requirements are that all broadcasting distribution undertakings (BDUs) must pass through to subscribers all video description contained in the programming signals they receive from broadcasters. In the case of smaller BDUs, however, the Commission is aware that there are certain technical, operational and cost concerns associated with making the upgrades necessary to enable them to pass such programming signals through to subscribers.
Accordingly, the Commission calls for comments on the requirements for the pass-through of programming containing video description that should apply to Class 2 and Class 3 BDUs, whether licensed or exempt, and to multipoint distribution systems (MDS) undertakings. The Commission will accept comments that it receives on or before April 19, 2005.
February 25, 2005
[10-1-o]
COMPETITION TRIBUNAL
COMPETITION ACT
Application for an order
Notice is hereby given that on February 11, 2005, an application pursuant to section 106(2) of the Competition Act, R.S.C. 1985, c. C-34, was filed with the undersigned at the Competition Tribunal by Burns Lake Native Development Corporation et al., relating to the rescission of the consent agreement.
Particulars of the orders sought:
(a) an order to rescind the consent agreement registered and filed on December 7, 2004, between the Commissioner of Competition, West Fraser Timber Co. Ltd. and West Fraser Mills Ltd., and in particular the divestitures and related terms contemplated therein;
(b) in the alternative, an order varying the terms of the consent agreement so as to incorporate terms to recognize the Applicants' rights and interests;
(c) an order staying the consent agreement pending the determination of the within application;
(d) in the alternative to c), an expedited hearing of the within application; and
(e) such further or other final or interim orders as the Tribunal deems just.
Notice is hereby given that any requests for leave to intervene in this matter must be filed with the Registrar on or before April 4, 2005.
The notice of application and accompanying documents may be examined at the Registry of the Tribunal or a copy may be obtained on the Competition Tribunal Web site at www.ct-tc.gc. ca. Requests for information regarding this application or the procedures of the Tribunal should be addressed to the Deputy Registrar, Competition Tribunal, 600-90 Sparks Street, Ottawa, Ontario K1P 5B4, (613) 954-0857 (telephone).
March 5, 2005
MONIQUE SÉGUIN
Registrar
[10-1-o]
HAZARDOUS MATERIALS INFORMATION REVIEW COMMISSION
HAZARDOUS MATERIALS INFORMATION REVIEW ACT
Decisions and orders on claims for exemption
Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Hazardous Materials Information Review Commission hereby gives notice of the decisions of the Screening Officer, respecting each claim for exemption and the relevant Material Safety Data Sheet (MSDS), listed below.
| Claimant | Product Identifier (As shown on the MSDS) |
Registry Number | MSDS Preparation Date (As shown on the MSDS) |
Date of Decision |
|---|---|---|---|---|
| Wilsonart International Inc., Temple, Texas |
Wilsonart® 3000 Adhesive |
4452 | 05/26/2000 | January 26, 2005 |
| Wilsonart International Inc., Temple, Texas |
Wilsonart® 3116 Adhesive |
4453 | 05/26/2000 | January 26, 2005 |
| Wilsonart International Inc., Temple, Texas |
Wilsonart® 3028 Adhesive |
4454 | 05/26/2000 | January 26, 2005 |
| Wilsonart International Inc., Temple, Texas |
Wilsonart® 3131 Adhesive |
4455 | 05/26/2000 | January 26, 2005 |
| Wilsonart International Inc., Temple, Texas |
Wilsonart® 3132 Adhesive |
4456 | 05/26/2000 | January 26, 2005 |
| Wilsonart International Inc., Temple, Texas |
Wilsonart® 3301 Adhesive |
4457 | 05/26/2000 | January 26, 2005 |
| Wilsonart International Inc., Temple, Texas |
Wilsonart® 3100 Adhesive |
4458 | 05/26/2000 | January 26, 2005 |
| Wilsonart International Inc., Temple, Texas |
Wilsonart® 3121 Adhesive |
4459 | 05/26/2000 | January 26, 2005 |
| Air Products and Chemicals Inc., formerly Air Products & Chemicals Inc. - Chemicals Group, Allentown, Pennsylvania |
ANCAMINE 2353 CURING AGENT |
4832 | May 2002 | January 4, 2005 |
| Cytec Industries Inc., formerly CYTEC INDUSTRIES INC., West Paterson, New Jersey |
BR 127 Corrosion Inhibiting Primer formerly BR+ 127 Corrosion Inhibiting Primer |
4840 | 11/16/2001 | January 24, 2005 |
| Cytec Industries Inc., formerly CYTEC INDUSTRIES INC., West Paterson, New Jersey |
BR 161 Corrosion Inhibiting Primer formerly BR+ 161 Corrosion Inhibiting Primer |
4841 | 11/16/2001 | January 24, 2005 |
| BYK-Chemie USA, Inc., Wallingford, Connecticut |
Disperbyk- 106 |
4860 | 01/01/2003 | November 9, 2004 |
| Ciba Specialty Chemicals Canada Inc., Mississauga, Ontario |
TINUVIN XT 850FF formerly EB 40-68 |
4863 | February 15, 2002 |
November 16, 2004 |
| Crompton Co./Cie, Elmira, Ontario formerly Witco Canada Inc., West Hill, Ontario |
MARKSTAT® AL-14 |
4913 | 2003.11.21 | December 13, 2004 |
| Air Products and Chemicals Inc., formerly Air Products & Chemicals Inc. - Chemicals Group, Allentown, Pennsylvania |
ANCAMINE 2334 CURING AGENT |
4942 | June 2002 | November 15, 2004 |
| Afton Chemical Corporation, formerly Ethyl Corporation, Richmond, Virginia |
HiTEC 536 Performance Additive |
4975 | 10/14/2002 | January 26, 2005 |
| Canada Colors and Chemicals Limited, Don Mills, Ontario |
EPI-REZ 3520-WY-55 |
4977 | Jan 31/ 2003 | December 30, 2004 |
| BYK-Chemie USA, Inc., Wallingford, Connecticut |
Disperbyk- 109 |
4984 | 03/12/2002 | January 31, 2005 |
| Air Products and Chemicals Inc., formerly Air Products & Chemicals Inc. - Chemicals Group, Allentown, Pennsylvania |
ANCAMINE 2280 CURING AGENT |
5017 | May 2002 | January 4, 2005 |
| BYK-Chemie USA, Inc., Wallingford, Connecticut |
Anti-Terra- 202 |
5023 | 03/27/2001 | November 5, 2004 |
| Nalco Canada Company, Burlington, Ontario formerly Nalco/Exxon Energy Chemicals Canada Inc., Calgary, Alberta |
SCALECHEK LP-60 formerly SCALECHEK LP |
5063 | 2001/04/04 | November 3, 2004 |
| Fusion, Inc., Willoughby, Ohio |
NPA-1070 -400 |
5069 | 1/20/03 | October 20, 2004 |
| BYK-Chemie USA, Inc., Wallingford, Connecticut |
Viscobyk- 4015 |
5075 | 04/19/2001 | October 19, 2004 |
| Baker Petrolite Corp., Sugar Land, Texas |
CRW100 CORROSION INHIBITOR formerly CRW0100Y CORROSION INHIBITOR |
5077 | 8/11/2003 | October 22, 2004 |
| Baker Petrolite Corp., Sugar Land, Texas |
CRW9152 CORROSION INHIBITOR | 5078 | 1/5/2004 | October 22, 2004 |
| Cognis Canada Corporation, Mississauga, Ontario |
CAPCURE WR-6 |
5081 | 01/23/2003 | December 21, 2004 |
| Teck Cominco Metals Ltd., formerly Cominco Ltd., Trail, British Columbia |
Germanium Dioxide Solution TG/0 formerly Germanium Oxide Solution GG/O |
5099 | December 18, 2002 |
December 22, 2004 |
| Teck Cominco Metals Ltd., formerly Cominco Ltd., Trail, British Columbia |
Germanium Dioxide Solution TG/11 formerly Germanium Oxide Solution GG/11 |
5100 | December 18, 2002 |
December 22, 2004 |
| Rohm and Haas Canada Inc., West Hill, Ontario |
PARALOID K-125 Processing Aid formerly PARALOID K-125 Modifier |
5116 | 09/22/03 | December 22, 2004 |
| BYK-Chemie USA, Inc., Wallingford, Connecticut |
BYK-W 995 | 5151 | 01/01/2002 | November 29, 2004 |
| BYK-Chemie USA, Inc., Wallingford, Connecticut |
Disperbyk- 110 |
5152 | 01/01/2002 | November 29, 2004 |
| Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
BEROL® DGR 81 |
5161 | 09/30/2003 | December 23, 2004 |
| Enthone, Inc., West Haven, Connecticut formerly Enthone-OMI (Canada) Inc., Mississauga, Ontario |
ENPLATE™ DSR-3241BR formerly Enplate (TM) DSR-3241BR |
5170 | August 09, 2001 |
October 21, 2004 |
| Schlumberger, Sugar Land, Texas |
Multifunctional Surfactant F105 |
5202 | 16- September- 2002 |
January 25, 2005 |
| Baker Petrolite Corp., Sugar Land, Texas |
BPR 81476 | 5209 | 8/11/2003 | October 22, 2004 |
| BYK-Chemie USA, Inc., Wallingford, Connecticut |
BYK-W 990 | 5210 | 09/06/2001 | November 2, 2004 |
| Enthone, Inc., West Haven, Connecticut formerly Enthone-OMI (Canada) Inc., Mississauga, Ontario |
ENPLATE™ USI-210WP formerly Enplate (TM) USI-210WP currently Enplate USI-210 WP-12 |
5218 | September 20, 2001 |
January 17, 2005 |
| Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
REDICOTE® C-2912 |
5228 | 12/16/2003 | October 26, 2004 |
| Ciba Specialty Chemicals Canada Inc., Mississauga, Ontario |
EB 41-63 FF | 5247 | October 22, 2001 | January 28, 2005 |
| Ciba Specialty Chemicals Canada Inc., Mississauga, Ontario |
EB 40-70 FF | 5249 | October 23, 2001 | January 26, 2005 |
| Air Products and Chemicals Inc., formerly Air Products & Chemicals Inc. - Chemicals Group, Allentown, Pennsylvania |
ANCAMINE* 2526 CURING AGENT |
5250 | September 2003 |
November 19, 2004 |
| Baker Petrolite Corp., Sugar Land, Texas |
CRO1950 CORROSION INHIBITOR | 5275 | 8/14/2002 | October 26, 2004 |
| Baker Petrolite Corp., Sugar Land, Texas |
TOLAD® 9037 FUEL ADDITIVE |
5290 | 3/21/2002 | November 4, 2004 |
| Cognis Canada Corporation, Mississauga, Ontario |
PHOTOMER 4173 |
5299 | 12/13/2001 | November 5, 2004 |
| PPG Phillips Industrial Coatings, Winnipeg, Manitoba |
794002 2C ACRYCOTE ACTIVATOR 4:1 formerly 2C ACRYCOTE ACTIVATOR 4:1 794002 |
5346 | 11/18/02 | December 15, 2004 |
| PPG Phillips Industrial Coatings, Winnipeg, Manitoba |
755000 2C ACRYCOTE ACTIVATOR 4:1 formerly 2C ACRYCOTE ACTIVATOR 4:1 PRE-REDU 755000 |
5347 | 07/29/02 | December 15, 2004 |
| PPG Phillips Industrial Coatings, Winnipeg, Manitoba |
758000 2C ACRYCOTE ELECTRICAL EQ formerly 2C ACRYCOTE ELEC EQUIPM 758000 |
5348 | 07/29/02 | December 15, 2004 |
| PPG Phillips Industrial Coatings, Winnipeg, Manitoba |
797000 2C ACRYCOTE FLAT ACTIVATO formerly 2C ACRYCOTE FLAT ACTIVATOR 797000 |
5349 | 07/29/02 | December 15, 2004 |
| 3M Canada Company, London, Ontario |
SCOTCH- WELD (TM) EPOXY ADHESIVE 420 OFF- WHITE (PART A) |
5373 | 02/24/2004 | November 19, 2004 |
| 3M Canada Company, London, Ontario |
SCOTCH- WELD (TM) EC-2615 B/A EPOXY ADHESIVE (PART A) |
5374 | 02/24/2004 | November 19, 2004 |
| 3M Canada Company, London, Ontario |
SCOTCH- WELD (TM) EC-3333 B/A EPOXY ADHESIVE (PART A) |
5375 | 02/24/2004 | November 19, 2004 |
| 3M Canada Company, London, Ontario |
SCOTCH- |
5376 | 26/02/2004 | November 19, 2004 |
| 3M Canada Company, London, Ontario |
3M (TM) AUTOMIX (TM) PANEL BONDING ADHESIVE, (PART A) (P.N. 08115) formerly 3M (TM) PANEL BONDING ADHESIVE, (PART A) (P.N. 08115) |
5378 | 02/04/2004 | November 25, 2004 |
| 3M Canada Company, London, Ontario |
SCOTCH- WELD (TM) AF-191 STRUCTURAL ADHESIVE FILM / PELLICULE ADHÉSIF STRUCTU- RALE "SCOTCH- WELD" AF-191 formerly "SCOTCH- WELD (TM) AF-191 STRUCTURAL ADHESIVE FILM" |
5381 | 26/02/2004 (English/ anglaise) 2002/03/21 (French/ française) |
November 25, 2004 |
| INEOS Oxide LLC, Houston, Texas |
GAS/SPEC CS-PLUS SOLVENT formerly Gas/Spec CS Plus Solvent |
5383 | 02/11/01 | January 7, 2005 |
| INEOS Oxide LLC, Houston, Texas |
GAS/SPEC CS-PLUS SOLVENT ADDITIVE formerly Gas/Spec CS Plus Solvent Additve |
5384 | 02/11/01 | January 7, 2005 |
| Borden Chemicals Canada, Ltd., Oshawa, Ontario formerly Borden Chemical - Canada, Division of the Borden Company, Toronto, Ontario |
StructurFast™ OS-518 formerly StructurFast (TM) OS-518 |
5393 | 10-JAN-03 | November 10, 2004 |
| Baker Petrolite Corp., Sugar Land, Texas |
TOLAD® 9076 FUEL ADDITIVE |
5394 | 8/14/2002 | November 4, 2004 |
| INEOS Oxide LLC, Houston, Texas |
GAS/SPEC CS-2000 GAS TREATING SOLVENT ADDITIVE formerly Gas Spec CS 2000 Solvent Additve |
5395 | 02/11/01 | January 7, 2005 |
| INEOS Oxide LLC, Houston, Texas |
GAS/SPEC ® CS-2000 GAS TREATING SOLVENT |
5396 | 02/11/01 | January 7, 2005 |
| INEOS Oxide LLC, Houston, Texas |
GAS/SPEC CS-2010 SOLVENT formerly Gas Spec CS 2010 Solvent |
5397 | 02/11/01 | January 7, 2005 |
| INEOS Oxide LLC, Houston, Texas |
GAS/SPEC CS-2020 SOLVENT |
5398 | 02/11/01 | January 7, 2005 |
| 3M Canada Company, London, Ontario |
3M (TM) INDUSTRIAL DEGREASER CONCENT- RATE (PRODUCT NO. 26, TWIST 'N FILL (TM) SYSTEM) formerly 3M BRAND INDUSTRIAL DEGREASER CONCENT- RATE (PRODUCT NO. 26, TWIST 'N FILL (TM) SYSTEM) |
5400 | 02/04/2004 | December 3, 2004 |
| Baker Petrolite Corp., Sugar Land, Texas |
TOLAD® 3514 FUEL ADDITIVE |
5411 | 11/19/2002 | November 26, 2004 |
| Ciba Specialty Chemicals Canada Inc., Mississauga, Ontario |
INVATEX AC |
5417 | 25-Nov-2003 | November 23, 2004 |
| Baker Petrolite Corp., Sugar Land, Texas |
SurfSweep™ CLW3060 |
5418 | 8/14/2002 | October 27, 2004 |
| Shamrock Technologies, Newark, New Jersey |
AQUAPEL | 5419 | 11/14/2003 | January 11, 2005 |
| Borden Chemicals Canada, Ltd., Oshawa, Ontario formerly Borden Chemical - Canada, Division of the Borden Company, Toronto, Ontario |
Cascophen HPC51 |
5432 | 30-SEPT-02 | November 10, 2004 |
| 3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING INK 9780 GLOSS CLEAR formerly 3M 9780 UV OVERPRINT CLEAR |
5434 | 27/02/2004 | December 3, 2004 |
| Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
BEROL® TFR DS |
5458 | 12/16/2003 | December 8, 2004 |
| Baker Petrolite Corp., Sugar Land, Texas |
RBW219 REVERSE BREAKER |
5461 | 9/4/2003 | November 1, 2004 |
| Baker Petrolite Corp., Sugar Land, Texas |
CRO9946DU CORROSION INHIBITOR | 5473 | 9/3/2003 | November 2, 2004 |
Akzo Nobel |
LILAMIN® AC-493L |
5486 | 12/16/2003 | October 26, 2004 |
| Surface Specialties, Inc., formerly UCB Chemicals Corporation, Smyrna, Georgia |
Ebecryl® 264 | 5499 | 01/30/2004 | January 27, 2005 |
| Surface Specialties, Inc., formerly UCB Chemicals Corporation, Smyrna, Georgia |
Ebecryl® 7100 |
5500 | 02/05/2004 | January 27, 2005 |
| Surface Specialties, Inc., formerly UCB Chemicals Corporation, Smyrna, Georgia |
Ebecryl® P115 |
5501 | 02/06/2004 | January 27, 2005 |
| 3M Canada Company, London, Ontario |
3M (TM) ALL PURPOSE CLEANER & DEGREASER; PN 38050, 38051, 38052, 38053 |
5556 | 2003/02/17 | January 4, 2005 |
| Huntsman Advanced Materials Americas Inc., formerly Vantico Inc., Brewster, New York |
Aradur 76 BD |
5584 | February 17, 2004 | January 28, 2005 |
| 3M Canada Company, London, Ontario |
3M (TM) PROTECTIVE CHEMICAL PM-1396 |
5613 | 15/04/2004 | December 9, 2004 |
| 3M Canada Company, London, Ontario |
3M (TM) PROTECTIVE CHEMICAL PM-1451 |
5614 | 15/04/2004 | December 9, 2004 |
| Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
C-6212 | 5684 | 07/11/2003 | December 23, 2004 |
| GE Canada Inc., Mississauga, Ontario |
Niax® silicone L-631 |
5819 | 2003.10.24 | November 26, 2004 |
| GE Canada Inc., Mississauga, Ontario |
Silcat® RHS Silane |
5825 | 2003.10.24 | December 15, 2004 |
| E.I. duPont Canada Company, Mississauga, Ontario |
ZONYL FSG | 5930 | 2-APR-2003 | January 28, 2005 |
Notes: 1. The Notice of Filing published in the Canada Gazette, Part I, on February 3, 2001, listed the subject of the claim bearing Registry Number 4860 to be the chemical identity and concentration of two ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of three ingredients.
2. The Notice of Filing published in the Canada Gazette, Part I, on May 5, 2001, listed the subject of the claim bearing Registry Number 5017 to be the chemical identity of two ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of two ingredients.
3. The Notice of Filing published in the Canada Gazette, Part I, on August 18, 2001, listed the subject of the claim bearing Registry Number 5069 to be the chemical identity and concentration of five ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of seven ingredients.
4. The Notice of Filing published in the Canada Gazette, Part I, on August 18, 2001, listed the subject of the claim bearing Registry Number 5100 to be the chemical identity of one ingredient. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of two ingredients.
5. The Notice of Filing published in the Canada Gazette, Part I, on November 3, 2001, listed the subject of the claim bearing Registry Number 5202 to be the chemical identity and concentration of two ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of two ingredients.
6. The Notice of Filing published in the Canada Gazette, Part I, on November 3, 2001, listed the subject of the claim bearing Registry Number 5210 to be the chemical identity of two ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of two ingredients.
7. The Notice of Filing published in the Canada Gazette, Part I, on November 3, 2001, listed the subject of the claim bearing Registry Number 5228 to be the chemical identity and concentration of four ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of two ingredients.
8. The Notice of Filing published in the Canada Gazette, Part I, on January 19, 2002, listed the subject of the claim bearing Registry Number 5247 to be the chemical identity of one ingredient. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of two ingredients.
9. The Notice of Filing published in the Canada Gazette, Part I, on July 20, 2002, listed the subjects of the claims bearing Registry Numbers 5373, 5374, 5375 and 5376 to be the chemical identities of two, three, two and two ingredients, respectively. The subjects of the claims on which the Screening Officer issued the decisions are the chemical identities of three, four, three and three ingredients, respectively.
10. The Notice of Filing published in the Canada Gazette, Part I, on July 20, 2002, listed the subject of the claim bearing Registry Number 5381 to be the chemical identity of one ingredient. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of three ingredients.
11. The Notice of Filing published in the Canada Gazette, Part I, on July 20, 2002, listed the subject of the claim bearing Registry Number 5393 to be the chemical identity of four ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of three ingredients.
12. The Notice of Filing published in the Canada Gazette, Part I, on July 20, 2002, listed the subject of the claim bearing Registry Number 5411 to be the chemical identity of three ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of two ingredients.
13. The Notice of Filing published in the Canada Gazette, Part I, on July 20, 2002, listed the subject of the claim bearing Registry Number 5434 to be the chemical identity of one ingredient. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of two ingredients.
14. The Notice of Filing published in the Canada Gazette, Part I, on December 14, 2002, listed the subject of the claim bearing Registry Number 5486 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of one ingredient.
15. The Notice of Filing published in the Canada Gazette, Part I, on July 26, 2003, listed the subject of the claim bearing Registry Number 5584 to be the chemical identity of one ingredient. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of two ingredients.
16. The Notice of Filing published in the Canada Gazette, Part I, on July 26, 2003, listed the subject of the claims bearing Registry Numbers 5613 and 5614 to be the chemical identity of two ingredients. The subject of the claims on which the Screening Officer issued the decisions is the chemical identity of one ingredient.
17. The Notice of Filing published in the Canada Gazette, Part I, on July 26, 2003, listed the subject of the claim bearing Registry Number 5684 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of one ingredient.
There were no submissions from affected parties to the Screening Officer with respect to any of the above claims for exemption and related MSDSs.
Each of the claims for exemption listed above was found to be valid. The Screening Officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations. Having regard for the various data readily available in the literature and any information provided by the claimant, the Screening Officer found that the respective MSDS relating to the claims bearing Registry Numbers 4984, 5075, 5116, 5151 and 5152 complied with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.
Having regard for the various data readily available in the literature and any information provided by the claimant, the Screening Officer found that the respective MSDS relating to the remaining claims did not comply with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.
Registry Number 4452
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of vinyl acetate in the controlled product, its CAS Registry Number 108-05-4 and its percent concentration;
2. Disclose the Exposure Limit Values ACGIH TLV-TWA = 10 ppm and ACGIH TLV-STEL = 15 ppm for vinyl acetate;
3. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause tumours in laboratory animals;
4. Disclose that an ingredient in the controlled product has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC);
5. Disclose that an ingredient in the controlled product has been shown to cause adverse reproductive effects in laboratory animals;
6. In relation to the first aid information shown on the MSDS for ingestion, remove the statements to give several glasses of fluids and to induce vomiting and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;
7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
Registry Number 4453
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;
2. Disclose the presence of polyvinyl alcohol in the controlled product, its CAS Registry Number 9002-89-5 and its percent concentration;
3. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause tumours in laboratory animals;
4. Disclose that an ingredient in the controlled product has been shown to cause adverse reproductive effects in laboratory animals;
5. In relation to the first aid information shown on the MSDS for ingestion, remove the statements to give several glasses of fluids and to induce vomiting and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;
6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
Registry Number 4454
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of vinyl acetate in the controlled product, its CAS Registry Number 108-05-4 and its percent concentration;
2. Disclose the Exposure Limit Values ACGIH TLV-TWA = 10 ppm and ACGIH TLV-STEL = 15 ppm for vinyl acetate;
3. Disclose the ACGIH TLV-TWA Exposure Limit Value for the confidential hazardous ingredient;
4. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause effects on the testes and liver of laboratory animals;
5. Disclose that an ingredient in the controlled product has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC);
6. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects and adverse reproductive effects in laboratory animals;
7. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity;
8. In relation to the first aid information shown on the MSDS for ingestion, remove the statements to give several glasses of fluids and to induce vomiting and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;
9. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
Registry Numbers 4455 and 4456
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause tumours in laboratory animals;
2. Disclose that an ingredient in the controlled product has been shown to cause adverse reproductive effects in laboratory animals;
3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A;
4. Registry Number 4455: In relation to the first aid information shown on the MSDS for ingestion, remove the statements to give several glasses of fluids and to induce vomiting and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;
5. Registry Number 4456: In relation to the first aid information shown on the MSDS for ingestion, remove the statement to induce vomiting and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration.
Registry Number 4457
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of vinyl acetate in the controlled product, its CAS Registry Number 108-05-4 and its percent concentration;
2. Disclose an LC50 (4 hours, vapour, female rat) value of 5 100 ppm for toluene;
3. Disclose the Exposure Limit Values ACGIH TLV-TWA = 10 ppm and ACGIH TLV-STEL = 15 ppm for vinyl acetate;
4. Remove contradictory statements concerning the flammability properties of the controlled product;
5. Disclose the Exposure Limit Values ACGIH TLV-TWA = 50 ppm (skin) and OSHA PEL-C of 300 ppm with a maximum peak of 500 ppm for toluene;
6. Disclose the ACGIH TLV-C Exposure Limit Value for the confidential hazardous ingredient;
7. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause tumours in laboratory animals;
8. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the immune system of laboratory animals;
9. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause loss of hearing in laboratory animals;
10. Disclose that an ingredient in the controlled product has been shown to cause skin irritation in laboratory animals;
11. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the bone marrow and liver as well as sperm effects in laboratory animals;
12. Disclose that acute inhalation of an ingredient of the controlled product has caused CNS effects and neurological impairment and that chronic inhalation has caused colour vision loss and neurological impairment;
13. Disclose that acetylsalicylic acid and hexane synergistically enhance the hearing loss caused by inhalation exposure to toluene in laboratory animals;
14. Disclose that an ingredient in the controlled product has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC);
15. Disclose that an ingredient in the controlled product has been shown to cause adverse reproductive effects in laboratory animals;
16. Disclose that an ingredient in the controlled product is considered to be a teratogen;
17. In relation to the first aid information shown on the MSDS for ingestion, remove the statements to give several glasses of fluids and to induce vomiting and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;
18. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or pulmonary resuscitation if breathing has stopped or the heart has stopped;
19. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D2A and D2B.
Registry Numbers 4458 and 4459
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;
2. Disclose the presence of polyvinyl alcohol in the controlled product, its CAS Registry Number 9002-89-5 and its percent concentration;
3. Disclose the ACGIH TLV-C Exposure Limit Value for the confidential hazardous ingredient;
4. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the bone marrow and liver as well as sperm effects in laboratory animals;
5. Disclose that an ingredient in the controlled product is considered to be a teratogen;
6. In relation to the first aid information shown on the MSDS for ingestion, remove the statements to give several glasses of fluids and to induce vomiting and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;
7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A;
8. Registry Number 4459:
(a)Disclose the presence of vinyl acetate in the controlled product, its CAS Registry Number 108-05-4 and its percent concentration;
(b) Disclose the Exposure Limit Values ACGIH TLV-TWA = 10 ppm and ACGIH TLV-STEL = 15 ppm for vinyl acetate;
(c) Disclose that an ingredient in the controlled product has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC).
Registry Number 4832
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the percent concentration of certain hazardous ingredients in an acceptable manner;
2. Disclose the Exposure Limit Value AIHA WEEL = 10 ppm for benzyl alcohol;
3. Disclose the Exposure Limit Value AIHA WEEL-TWA = 1 ppm (skin) for triethylenetetramine;
4. Disclose that an ingredient in the controlled product has been shown to be corrosive to the eyes of laboratory animals;
5. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 20–30 minutes;
6. Disclose an LD50 (dermal, rabbit) value of 550 mg/kg for triethylenetetramine;
7. Disclose an LD50 value for one of the confidential hazardous ingredients in an acceptable manner;
8. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human and bacterial cells, in vitro;
9. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.
Registry Number 4840
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for at least 15 minutes or until the chemical is removed;
2. Amend the MSDS to describe the subheading Odour Threshold as "not applicable";
3. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the adrenal glands of laboratory animals;
4. Disclose that an ingredient in the controlled product has shown positive results in a screening test for mutagenicity.
Registry Number 4841
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of 2-methoxy-1-propanol in the controlled product, its CAS Registry Number 1589-47-5 and its percent concentration;
2. Revise the MSDS to show that strontium chromate has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH);
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for at least 15 minutes or until the chemical is removed;
4. Disclose oxides of carbon, chromium and nitrogen as hazardous combustion products;
5. Disclose a lower LD50 (oral, rat) value of 3 739 mg/kg for 1-methoxy-2-propanol;
6. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the immune system of laboratory animals;
7. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;
8. Disclose the synergistic potential of halogenated hydrocarbons.
Registry Number 4860
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product;
2. Disclose that an ingredient in the controlled product is a skin sensitizer.
Registry Number 4863
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
Registry Number 4913
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose an LD50 value for the confidential hazardous ingredient in an acceptable manner.
Registry Number 4942
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with lukewarm, gently flowing water for at least 20–30 minutes;
2. Disclose an LC50 (4 hours, vapour, rat) value of 233 ppm for furfuryl alcohol;
3. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause nose and kidney tumours in laboratory animals;
4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.
Registry Number 4975
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for ingestion, remove the statements to give water to drink;
2. Add oxides of nitrogen to the list of hazardous decomposition products.
Registry Number 4977
The claimant has been ordered to amend certain aspects of the content and wording of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Eliminate the double entries found on the MSDS related to the ingredient with CAS Number 2807-30-9;
2. Disclose a lower LD50 (dermal, rabbit) value of 880 mg/kg for the ingredient with CAS Number 2807-30-9;
3. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;
4. Disclose that modified bisphenol A-ECH based epoxy resin has been shown to cause respiratory sensitization in workers.
Registry Number 5017
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the percent concentration of certain hazardous ingredients in an acceptable manner;
2. Disclose the Exposure Limit Value AIHA WEEL = 10 ppm for benzyl alcohol;
3. Disclose that an ingredient in the controlled product has been shown to be corrosive to the eyes of laboratory animals;
4. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 20–30 minutes;
5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human and bacterial cells, in vitro.
Registry Number 5023
The claimant has been ordered to amend certain aspects of the content of the MSDS.
Registry Number 5063
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 20–30 minutes;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20–30 minutes;
3. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;
4. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or pulmonary resuscitation if breathing has stopped or the heart has stopped;
5. Disclose an LC50 (30 minutes, mouse, aerosol) value of 3 200 mg/m3 for hydrochloric acid;
6. Disclose that an ingredient in the controlled product has been shown to cause fetotoxicity in laboratory animals;
7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1A and D2A.
Registry Number 5069
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose Exposure Limit Values for two of the confidential hazardous ingredients;
2. Disclose that an ingredient in the controlled product is incompatible with methanol, 2-propanol and diborane;
3. Disclose an LD50 (oral, female rat) value of 408 mg/kg for barium chloride;
4. Disclose that an ingredient in the controlled product has shown positive test results in an in vivo screening test for mutagenicity, and disclose that another ingredient in the controlled product has shown positive test results in an in vitro screening test for mutagenicity.
Registry Numbers 5077, 5078 and 5209
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E;
2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 20–30 minutes;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 20–30 minutes;
4. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;
5. Disclose that an ingredient in the controlled product is incompatible with acetyl bromide, aluminum and magnesium metals, aluminum and zinc salts, boron trichloride and cyanuric chloride;
6. Disclose an LC50 (4 hours, rat) value of 16 970 ppm for isopropyl alcohol;
7. Disclose an LC50 (4 hours, rat) value of 50 000 ppm for methanol;
8. Disclose that acute ingestion of an ingredient in the controlled product has caused adverse CNS and vision effects as well as necrosis and haemorrhaging in the brain;
9. Disclose that acute inhalation and dermal exposure to an ingredient in the controlled product have caused adverse vision and CNS effects;
10. Disclose that acute ingestion of a second ingredient in the controlled product has been shown to cause CNS effects;
11. Disclose that an ingredient in the controlled product has been shown to be mutagenic, in vivo;
12. Disclose that chronic inhalation of an ingredient in the controlled product has caused diminished vision;
13. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular effects in laboratory animals;
14. Disclose that an ingredient in the controlled product has been shown to cause skin corrosion in laboratory animals;
15. Registry Number 5078:
(a) Disclose that chronic skin contact with an ingredient in the controlled product has been shown to cause thyroid gland and liver effects in laboratory animals;
(b) Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause liver and kidney damage in laboratory animals; and
(c) Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse effects on the respiratory system, kidneys, male reproductive system and blood of laboratory animals.
Registry Number 5081
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose Exposure Limit Values for one of the confidential hazardous ingredients;
2. Disclose an LD50 value and an LC50 value for one of the confidential hazardous ingredients;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 20–30 minutes or until the chemical is removed;
4. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with lukewarm, gently flowing water for at least 20–30 minutes or until the chemical is removed;
5. In relation to the first aid information shown on the MSDS for ingestion, remove the statements to give water to drink;
6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.
Registry Numbers 5099 and 5100
The claimant has been ordered to amend certain aspects of the content and wording of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the lower LD50 (oral, female rat) value of 4 000 mg/kg for ethylene glycol;
2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with lukewarm, gently flowing water for at least 20–30 minutes and that medical advice should be obtained immediately;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 20–30 minutes and that medical advice should be obtained immediately;
4. Registry Number 5099:
(a) If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A; and
(b) Correct the impression that the controlled product is merely irritating as opposed to being a corrosive material;
5. Registry Number 5100:
(a) Disclose that the controlled product is corrosive to the eyes and skin; and
(b) If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D2A and E.
Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the Screening Officer.
Registry Number 5161
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for at least 15 minutes or until the chemical is removed;
2. Correct the contradictory information pertaining to the physical properties of cloud point and pour point;
3. Disclose an LD50 value for one of the confidential hazardous ingredients in an acceptable manner.
Registry Number 5170
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the Exposure Limit Value ACGIH TLV-TWA = 20 ppm for 2-butoxyethanol acetate;
2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
4. In relation to the first aid information shown on the MSDS for ingestion, delete the statement "Give large amounts of water." Disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
Registry Number 5202
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or pulmonary resuscitation if breathing has stopped or the heart has stopped;
2. Disclose the Exposure Limit Values ACGIH TLV-TWA = 20 ppm and OSHA PEL = 100 ppm for butan-1-ol;
3. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause tumours in laboratory animals;
4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human cells, in vitro;
5. Disclose that ingredients in the controlled product have been shown to cause skin irritation in laboratory animals;
6. Disclose the lower LD50 (oral, rabbit) value of 320 mg/kg and disclose a lower LD50 (dermal, rabbit) value of 99 mg/kg for 2-butoxyethanol;
7. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and teratogenic effects in laboratory animals;
8. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1A and D2A.
Registry Number 5210
The claimant has been ordered to amend certain aspects of the content of the MSDS.
Registry Number 5218
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, salts with montmorillonite in the controlled product, their CAS Registry Number 68911-87-5 and their percent concentration;
2. Disclose an LD50 value for one of the confidential hazardous ingredients in an acceptable manner;
3. Disclose an Exposure Limit Value AIHA WEEL = 1 mg/m3 with a skin notation for one of the confidential hazardous ingredients;
4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro;
5. In relation to the first aid information shown on the MSDS for ingestion, delete the statement "give large amounts of water."
Registry Number 5228
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
Acknowledgement: Subsequent to the issuance of the decision and order on the claim for exemption, the claimant advised the Commission that sales in Canada of the relevant controlled product has ceased. Consequently, the order issued by the Screening Officer has effect only if the controlled product is again offered for sale in Canada.
Registry Number 5247
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS Registry Number and percent concentration;
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give a conscious casualty large quantities of water to drink.
Registry Number 5249
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give a conscious casualty large quantities of water to drink.
Registry Number 5250
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with lukewarm, gently flowing water for at least 20–30 minutes;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with lukewarm, gently flowing water for at least 20–30 minutes;
3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water to drink;
4. Disclose LD50 values for three of the confidential hazardous ingredients in an acceptable manner;
5. Disclose that ingredients in the controlled product have been shown to cause mutagenic effects in mammalian cells, in vitro;
6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.
Registry Number 5275
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E;
2. Correct the impression that xylene and trimethylbenzenes are regulated components of the controlled product;
3. Disclose the Exposure Limit Values ACGIH TLV-TWA = 200 ppm and ACGIH TLV-STEL = 400 ppm for isopropyl alcohol;
4. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 20–30 minutes;
5. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 20–30 minutes. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
6. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
7. Disclose that an ingredient in the controlled product is incompatible with acetyl bromide, aluminum and magnesium metals, aluminum and zinc salts, boron trichloride and cyanuric chloride;
8. Disclose an LC50 (4 hours, rat) value of 16 970 ppm for isopropyl alcohol;
9. Disclose an LC50 (4 hours, rat) value of 50 000 ppm for methanol;
10. Disclose that acute ingestion of an ingredient in the controlled product has caused adverse CNS and vision effects as well as necrosis and haemorrhaging in the brain;
11. Disclose that chronic inhalation of an ingredient in the controlled product has caused diminished vision;
12. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular effects in laboratory animals;
13. Disclose that an ingredient in the controlled product has been shown to be mutagenic, in vivo;
14. Disclose that an ingredient in the controlled product has been shown to cause skin corrosion in laboratory animals.
Registry Number 5290
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B;
2. Correct the impression that trimethylbenzenes are regulated components of the controlled product;
3. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;
4. Add oxides of sulphur to the list of hazardous combustion products;
5. Disclose an LD50 value for one of the confidential hazardous ingredients in an acceptable manner;
6. Disclose an LC50 value for one of the confidential hazardous ingredients in an acceptable manner;
7. Disclose an LD50 (oral, rat) value of 3 523 mg/kg for xylene;
8. Disclose that inhalation of an ingredient in the controlled product has been shown to cause fetotoxicity and postnatal developmental toxicity in laboratory animals;
9. Disclose that hexane synergistically enhances the hearing loss caused by inhalation exposure to xylene in laboratory animals.
Registry Number 5299
The claimant has been ordered to amend certain aspects of the format of the MSDS.
Registry Number 5346
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B;
2. Disclose the Exposure Limit Value ACGIH TLV-TWA = 20 ppm for N-butyl alcohol;
3. Disclose a lower LD50 (oral, female rat) value of 10.8 g/kg and an LC50 (4 hour, aerosol, rat) value of 160 ppm for N-butyl acetate;
4. Disclose a lower LD50 (oral, rat) value of 3 523 mg/kg and an LC50 (4 hours, rat) value of 6 350 ppm for xylene;
5. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause loss of hearing in laboratory animals;
6. Disclose that hexane synergistically enhances the hearing loss caused by inhalation exposure to xylene in laboratory animals.
Registry Numbers 5347 and 5348
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A;
2. Disclose a lower LD50 (oral, rat) value of 3 739 mg/kg and a LC50 (4 hours, rat) value of 15 000 ppm for propylene glycol monomethyl ether;
3. Disclose a lower LD50 (dermal, female rabbit) value of 99 mg/kg and disclose an LD50 (oral, rabbit) value of 320 mg/kg for 2-butoxyethanol;
4. Disclose a lower LD50 (oral, rat) value of 3 523 mg/kg and an LC50 (4 hours, rat) value of 6 350 ppm for xylene;
5. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause loss of hearing in laboratory animals;
6. Disclose that inhalation of an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;
7. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human and bacterial cells, in vitro;
8. Registry Number 5347: Disclose that an ingredient in the controlled product has been shown to cause reproductive and fetotoxic effects in laboratory animals at maternally toxic dose levels;
9. Registry Number 5348:
(a) Disclose the Exposure Limit Value ACGIH TLV-TWA = 20 ppm for N-butyl alcohol;
(b) Disclose a lower LD50 (oral, female rat) value of 10.8 g/kg and an LC50 (4 hour, aerosol, rat) value of 160 ppm for N-butyl acetate; and
(c) Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause CNS effects in laboratory animals.
Registry Number 5349
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B;
2. Disclose a lower LD50 (oral, female rat) value of 10.8 g/kg and an LC50 (4 hour, aerosol, rat) value of 160 ppm for N-butyl acetate;
3. Disclose a lower LD50 (oral, female rat) value of 4 328 mg/kg and a LC50 (4 hours, rat) value of 5 100 ppm for toluene;
4. Disclose that ingestion of an ingredient of the controlled product has caused liver, kidney and heart effects as well as harmful CNS effects;
5. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause brain damage and hearing loss as well as affect the immune system in laboratory animals;
6. Disclose that chronic inhalation of an ingredient in the controlled product has caused colour vision loss in humans and has been shown to cause hearing loss in laboratory animals;
7. Disclose that acetylsalicylic acid and hexane synergistically enhance the hearing loss caused by inhalation exposure to toluene in laboratory animals.
Registry Numbers 5373 to 5376, inclusive
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with water for at least 20–30 minutes;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20–30 minutes;
3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "Give victim two glasses of water";
4. Add oxides of sulphur to the list of hazardous combustion products.
Registry Number 5378
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with water for at least 20–30 minutes;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20–30 minutes;
3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "Give victim two glasses of water";
4. Add oxides of nitrogen to the list of hazardous combustion products.
Registry Number 5381
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "Give victim two glasses of water";
2. Disclose an LD50 (oral, male rat) value of 730 mg/kg and an LD50 (oral, female rat) value of 630 mg/kg for N,N,N',N' - tetraglycidyl-m-xylenediamine;
3. Disclose that N,N,N',N' - tetraglycidyl-m-xylenediamine has been shown to cause dermal sensitization in laboratory animals.
Registry Number 5383
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose LD50 values for the confidential hazardous ingredient in an acceptable manner;
2. Disclose a lower LD50 (oral, rat) value of 1 945 mg/kg for methyldiethanolamine;
3. Remove the statement to the effect that there was no indication of teratogenic or embryotoxic effects in tests performed on certain unspecified components;
4. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration and that medical attention should be sought immediately;
5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class B3.
Registry Number 5384
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Remove the statements to the effect that exposure is unlikely to cause teratogenic or embryotoxic effects;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20–30 minutes.
Registry Number 5393
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for ingestion, delete the statements to drink water;
2. Disclose an LC50 value for one of the confidential hazardous ingredients in an acceptable manner.
Registry Number 5394
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Correct the impression that xylene and trimethylbenzenes are regulated components of the controlled product;
2. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;
3. Disclose an LD50 (oral, rat) value of 2 050 mg/kg for 2-ethylhexanol.
Registry Number 5395
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Correct the implication that methyldiethanolamine is an ingredient of the controlled product;
2. Remove the concentration range shown for the confidential hazardous ingredient proprietary modified alkanolamine and disclose its actual concentration or an acceptable range value.
Registry Numbers 5396 to 5398, inclusive
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 20–30 minutes and that medical attention should be obtained immediately;
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give a casualty large quantities of water or milk to drink;
3. Registry Number 5396: Remove the concentration range shown for the confidential hazardous ingredient proprietary modified alkylamine and disclose its actual concentration or an acceptable range value.
Registry Number 5400
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for eye contact, disclose that flushing should continue for at least 60 minutes;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose that flushing should continue for at least 60 minutes or until the chemical is removed;
3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "Give victim two glasses of water";
4. Add oxides of nitrogen to the list of hazardous combustion products;
5. Disclose an LD50 (dermal, rabbit) value of 12.9 g/kg and an LC50 (4 hours, rat) value of 17 000 ppm for isopropanol;
6. Disclose an LD50 (oral, rat) value of 7.46 mL/kg and an LD50 (dermal, rabbit) value of 2.52 mL/kg for diethylene glycol mono (2-ethylhexyl) ether;
7. Disclose an LD50 (oral, male mouse) value of 536 mg/kg for trimethyl octadecyl ammonium chloride;
8. Disclose an LD50 (oral, rat) value of 3 080 mg/kg and an LD50 (dermal, rabbit) value of 2 120 mg/kg for 2-hexyl-ethyloxyethanol;
9. Disclose that skin contact can cause corrosion;
10. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular and kidney effects in laboratory animals;
11. Disclose that trimethyl octadecyl ammonium chloride is a dermal sensitizer in laboratory animals;
12. Disclose that an ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;
13. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D2A and E.
Registry Number 5411
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 20 minutes;
3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
4. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or pulmonary resuscitation if breathing has stopped or the heart has stopped;
5. Disclose an LC50 (4 hours, female rat) value of 5 100 ppm for toluene;
6. Disclose an LD50 (dermal, rabbit) value of 99 mg/kg and an LC50 (4 hour, rat) value of 450 ppm for 2-butoxyethanol;
7. Disclose that ingestion of an ingredient of the controlled product has resulted in death;
8. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on sperm production in laboratory animals;
9. Disclose that acetylsalicylic acid and hexane synergistically enhance the hearing loss caused by inhalation exposure to toluene in laboratory animals;
10. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause hearing loss and adverse urinary bladder and heart effects in laboratory animals;
11. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause permanent hearing loss as well as damage to the nasal cavity in laboratory animals;
12. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause tumours in laboratory animals;
13. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human cells, in vitro;
14. Disclose that inhalation of an ingredient in the controlled product has been shown to cause fetotoxicity and postnatal developmental toxicity in laboratory animals;
15. Disclose that chronic inhalation of an ingredient in the controlled product has caused colour vision loss;
16. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals.
Registry Number 5417
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Correct the impression that the controlled product is merely irritating as opposed to being a corrosive material;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20–30 minutes. Also disclose that contaminated clothing should be removed under running water;
3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement such as the following: Never give anything by mouth if the casualty is rapidly losing consciousness, or is unconscious or convulsing;
4. Disclose oxides of carbon as hazardous combustion products;
5. Disclose an LD50 value for one of the confidential hazardous ingredients in an acceptable manner.
Registry Number 5418
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
2. Disclose that an ingredient in the controlled product is incompatible with acetyl bromide, aluminum and magnesium metals, aluminum and zinc salts, boron trichloride and cyanuric chloride;
3. Disclose an LC50 (4 hours, rat) value of 50 000 ppm for methanol;
4. Disclose that acute ingestion of an ingredient in the controlled product has caused adverse CNS and vision effects as well as necrosis and haemorrhaging in the brain;
5. Disclose an LD50 value for one of the confidential hazardous ingredients in an acceptable manner;
6. Disclose that chronic inhalation of the ingredient has been shown to cause adverse liver effects;
7. Disclose that an ingredient in the controlled product has been shown to be mutagenic, in vivo.
Registry Number 5419
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Remove the notation in section 2 of the MSDS indicating that LD50 values are not available;
2. Disclose oxides of carbon as hazardous combustion products;
3. Correct the impression that the controlled product is merely mildly irritating as opposed to being a severely irritating material;
4. Remove the notation indicating that information pertaining to toxicity to the reproductive system and teratogenic effects is not available.
Registry Number 5432
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for ingestion, delete the statements to drink water.
Registry Number 5434
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "Give victim two glasses of water."
Registry Number 5458
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for at least 15 minutes or until the chemical is removed.
Registry Number 5461
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 20–30 minutes;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 20–30 minutes;
3. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
4. Disclose that an ingredient in the controlled product is incompatible with acetyl bromide, aluminum and magnesium metals, aluminum and zinc salts, boron trichloride and cyanuric chloride;
5. Disclose an LC50 (4 hours, rat) value of 50 000 ppm for methanol;
6. Disclose an LC50 (30 minutes, mouse, aerosol) value of 3 200 mg/m3 for hydrochloric acid;
7. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause necrosis and haemorrhaging in the brain;
8. Disclose that chronic inhalation of the ingredient has been shown to cause adverse liver effects;
9. Disclose that an ingredient in the controlled product has been shown to be mutagenic, in vivo.
Registry Number 5473
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Correct the impression that xylene and trimethylbenzenes are regulated components of the controlled product;
2. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
3. Disclose an LC50 (4 hours, rat) value of 16 970 ppm for isopropyl alcohol;
4. Disclose that ingestion of an ingredient in the controlled product can cause adverse central nervous system (CNS) effects and gastrointestinal disturbances in humans;
5. Disclose an LD50 (oral, rat) value of 9 g/kg for No. 2 diesel fuels;
6. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular effects in laboratory animals.
Registry Number 5486
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for at least 20 minutes or until the chemical is removed.
Registry Numbers 5499 to 5501, inclusive
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;
2. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;
3. Registry Number 5500:
(a)Disclose the percent concentration of hexamethylene diacrylate in an acceptable manner;
(b)Add oxides of nitrogen to the list of hazardous combustion products;
4. Registry Numbers 5499 and 5500:
(a)Disclose the Exposure Limit Value AIHA WEEL-TWA = 1 mg/m3 (skin, DSEN) for 1,6-hexanediol diacrylate;
(b)Disclose an LD50 (dermal, rabbit) value of 3 600 mg/kg for 1,6-hexanediol diacrylate.
Registry Number 5556
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of methanol in the controlled product, its CAS Registry Number 67-56-1 and its percent concentration;
2. Add oxides of nitrogen and phosphorus to the list of hazardous combustion products;
3. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity;
4. Disclose that ingredients in the controlled product are considered to be fetotoxins;
5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
Registry Number 5584
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B;
2. Disclose the presence of an additional confidential hazardous ingredient in the controlled product;
3. Remove the information pertaining to the LD50 range values for certain of the ingredients in the controlled product;
4. Disclose an LD50 (oral, rat) value of 580 mg/kg and an LD50 (dermal, rabbit) value of 2 010 mg/kg for nonylphenol;
5. Disclose LD50 values for one of the confidential hazardous ingredients in an acceptable manner;
6. Disclose that ingredients in the controlled product have been shown to cause mutagenic effects in mammalian cells, in vitro;
7. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20–30 minutes.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.
Registry Numbers 5613 and 5614
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eye should be washed with water for 20 minutes or until the chemical is removed;
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "Give victim two glasses of water."
Registry Number 5684
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Delete the statement which indicates that the ingredients quaternary ammonium compound (#1) and alkylarylsulfonate are WHMIS confidential ingredients;
2. In relation to the first aid information shown on the MSDS for ingestion, clarify that fluid is to be administered only under medical supervision. Add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
3. Disclose the Exposure Limit Values ACGIH TLV-TWA = 200 ppm and ACGIH TLV-STEL = 400 ppm for isopropanol;
4. Disclose that an ingredient in the controlled product is incompatible with aluminum powder, potassium tert-butoxide, and 2-butanone;
5. Disclose an LC50 (4 hours, rat) value of 16 970 ppm for isopropanol;
6. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause gastrointestinal tract disturbances;
7. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular and kidney effects in laboratory animals;
8. Disclose that an ingredient in the controlled product has been shown to cause fetotoxicity in laboratory animals;
9. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
Registry Number 5819
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of isopropanol in the controlled product, its CAS Registry Number 67-63-0 and its percent concentration;
2. Correct the impression that polyalkylene oxide 2 is a regulated component of the controlled product;
3. Disclose the Exposure Limit Values ACGIH TLV-TWA = 200 ppm and ACGIH TLV-STEL = 400 ppm for isopropyl alcohol;
4. Disclose that inhalation of an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals and that ingestion of that same ingredient has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels.
Registry Number 5825
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Delete the statement which indicates that the ingredients proprietary additives are WHMIS confidential ingredients;
2. In relation to the first aid information shown on the MSDS for ingestion, delete the statements to give water to drink and to induce vomiting and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 20–30 minutes;
4. In relation to the first aid information shown on the MSDS for eye contact, disclose that immediate medical attention should be sought in all cases, and that flushing should continue for at least 20–30 minutes;
5. Correct the impression that the controlled product is irritating as opposed to being a corrosive material;
6. Disclose that an ingredient in the controlled product has been shown to cause skin corrosion in laboratory animals;
7. Disclose that inhalation of an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;
8. Disclose a calculated LD50 (oral, rat) value of 2 900 mg/kg for the controlled product;
9. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.
Registry Number 5930
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for at least 15 minutes or until the chemical is removed;
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink and add a statement that medical attention should be obtained;
3. Disclose that chronic inhalation exposure to an ingredient in the controlled product has been shown to cause neurotoxic effects in laboratory animals.
Having regard to the foregoing, and pursuant to section 17 of the Hazardous Materials Information Review Act, notice is hereby given that the Screening Officer has, for each of the above-noted claims, with the exceptions of those claims bearing Registry Numbers 4984, 5075, 5116, 5151 and 5152, directed the claimant to comply with the provisions of the Hazardous Products Act and the Controlled Products Regulations within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the Screening Officer within 40 days of expiry of the appeal period.
Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, this notice includes certain information which, in the opinion of the Screening Officer, should have been shown on the relevant MSDS.
Pursuant to subsection 24(1) of the Controlled Products Regulations, amended MSDSs must be available in both official languages.
Section 20 of the Hazardous Materials Information Review Act affords the opportunity to a claimant or any affected party, within the meaning of subsection 2(2) of the Hazardous Materials Information Review Regulations, to appeal a decision or order of a Screening Officer. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered within 45 days of the publication of this notice in the Canada Gazette, Part I, to the Chief Appeals Officer at the following address: Hazardous Materials Information Review Commission, 427 Laurier Avenue W, 7th Floor, Ottawa, Ontario K1A 1M3, (613) 993-4429.
R. BOARDMAN
Chief Screening Officer
[10-1-o]
NAFTA SECRETARIAT
COMPLETION OF PANEL REVIEW
Wood venetian blinds and slats (Injury)
Notice is hereby given, pursuant to subrule 78(a) of the NAFTA Article 1904 Panel Rules, that the binational panel review of the findings made by the Canadian International Trade Tribunal, respecting Wood Venetian Blinds and Slats originating in or exported from Mexico, is completed. Pursuant to subrule 78(a) of the NAFTA Article 1904 Panel Rules, this Notice of Completion of Panel Review is effective on February 23, 2005, the day the consent motion to terminate the binational panel review of this matter was filed (Secretariat File No. CDA-MEX-2004-1904-01).
Explanatory note
Chapter 19 of the North American Free Trade Agreement establishes a procedure for replacing domestic judicial review of determinations in anti-dumping and countervailing duty cases involving imports from a NAFTA country with review by binational panels.
These panels are established, when a Request for Panel Review is received by the NAFTA Secretariat, to act in place of national courts to review final determinations expeditiously to determine whether they are in accordance with the anti-dumping or countervailing duty law of the country that made the determination.
Under Article 1904 of the North American Free Trade Agreement, which came into force on January 1, 1994, the Government of Canada, the Government of the United States and the Government of Mexico established the Rules of Procedure for Article 1904 Binational Panel Reviews. These Rules were published in the Canada Gazette, Part I, on January 1, 1994.
Requests for information concerning the present notice, or concerning the NAFTA Article 1904 Panel Rules, should be addressed to the Canadian Secretary, NAFTA Secretariat, Canadian Section, 90 Sparks Street, Suite 705, Ottawa, Ontario K1P 5B4, (613) 992-9388.
FRANÇOY RAYNAULD
Canadian Secretary
[10-1-o]
NAFTA SECRETARIAT
WITHDRAWAL OF REQUEST FOR PANEL REVIEW
Certain softwood lumber products from Canada
Notice is hereby given that the Request for Panel Review of the Notice of Implementation Under Section 129 of the Uruguay Round Agreements Act; Countervailing Measures made by the United States Department of Commerce, International Trade Administration, concerning Certain Softwood Lumber Products from Canada, has been withdrawn by the requesters as of February 17, 2005 (Secretariat File No. USA-CDA-2005-1904-02). No complaints were filed pursuant to rule 39, no notices of appearance were filed pursuant to rule 40 and no panel has been appointed.
Explanatory note
Chapter 19 of the North American Free Trade Agreement establishes a procedure for replacing domestic judicial review of determinations in anti-dumping and countervailing duty panel reviews involving imports from a NAFTA country with review by binational panels.
These panels are established, when a Request for Panel Review is received by the NAFTA Secretariat, to act in place of national courts to review final determinations expeditiously to determine whether they are in accordance with the anti-dumping or countervailing duty law of the country that made the determination.
Under Article 1904 of the North American Free Trade Agreement which came into force on January 1, 1994, the Government of Canada, the Government of the United States and the Government of Mexico established the NAFTA Article 1904 Panel Rules. These Rules were published in the Canada Gazette, Part I, on January 1, 1994.
Requests for information concerning the present notice, or concerning the NAFTA Article 1904 Panel Rules, should be addressed to the Canadian Secretary, NAFTA Secretariat, Canadian Section, 90 Sparks Street, Suite 705, Ottawa, Ontario K1P 5B4, (613) 992-9388.
FRANÇOY RAYNAULD
Canadian Secretary
[10-1-o]
NOTICE:
The format of the electronic version of this issue of the Canada Gazette was modified in order to be compatible with extensible hypertext markup language (XHTML 1.0 Strict).
